SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Organovo Holdings, Inc. – ‘10-Q’ for 6/30/13 – ‘R5’

On:  Friday, 8/9/13, at 5:20pm ET   ·   For:  6/30/13   ·   Accession #:  1193125-13-329393   ·   File #:  1-35996

Previous ‘10-Q’:  ‘10-Q’ on 11/14/12 for 9/30/12   ·   Next:  ‘10-Q’ on 11/8/13 for 9/30/13   ·   Latest:  ‘10-Q’ on 2/8/24 for 12/31/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/09/13  Organovo Holdings, Inc.           10-Q        6/30/13   79:9.3M                                   Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    413K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     29K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     29K 
 4: EX-32.1     Exhiibt 32.1                                        HTML     23K 
77: R1          Document and Entity Information                     HTML     42K 
48: R2          Condensed Consolidated Balance Sheets               HTML    104K 
44: R3          Condensed Consolidated Balance Sheets               HTML     34K 
                (Parenthetical)                                                  
14: R4          Condensed Consolidated Statements of Operations     HTML     75K 
                (Unaudited)                                                      
47: R5          Condensed Consolidated Statements of Stockholders'  HTML    125K 
                Equity (Deficit) (Unaudited)                                     
28: R6          Condensed Consolidated Statements of Cash Flows     HTML    128K 
                (Unaudited)                                                      
65: R7          Condensed Consolidated Statements of Cash Flows     HTML     45K 
                (Unaudited) (Parenthetical)                                      
29: R8          Change in Fiscal Year End                           HTML     25K 
34: R9          Description of Business and Summary of Significant  HTML     94K 
                Accounting Policies                                              
15: R10         Derivative Liability                                HTML     46K 
31: R11         Stockholders' Equity                                HTML     96K 
64: R12         Commitments and Contingencies                       HTML     44K 
59: R13         Concentrations                                      HTML     28K 
45: R14         Subsequent Events                                   HTML     33K 
72: R15         Description of Business and Summary of Significant  HTML    170K 
                Accounting Policies (Policies)                                   
62: R16         Description of Business and Summary of Significant  HTML     48K 
                Accounting Policies (Tables)                                     
13: R17         Derivative Liability (Tables)                       HTML     38K 
18: R18         Stockholders' Equity (Tables)                       HTML     86K 
71: R19         Commitments and Contingencies (Tables)              HTML     30K 
76: R20         Description of Business and Summary of Significant  HTML     33K 
                Accounting Policies (Details)                                    
78: R21         Description of Business and Summary of Significant  HTML     38K 
                Accounting Policies (Details 1)                                  
74: R22         Description of Business and Summary of Significant  HTML    240K 
                Accounting Policies (Details Textual)                            
56: R23         Derivative Liability (Details)                      HTML     36K 
16: R24         Derivative Liability (Details Textual)              HTML     44K 
27: R25         Stockholders' Equity (Details)                      HTML     34K 
22: R26         Stockholders' Equity (Details 1)                    HTML     58K 
21: R27         Stockholders' Equity (Details 2)                    HTML     36K 
35: R28         Stockholders' Equity (Details 3)                    HTML     50K 
55: R29         Stockholders' Equity (Details 4)                    HTML     27K 
61: R30         Stockholders' Equity (Details Textual)              HTML    273K 
24: R31         Commitments and Contingencies (Details)             HTML     35K 
36: R32         Commitments and Contingencies (Details Textual)     HTML     31K 
68: R33         Subsequent Events (Details Textual)                 HTML     66K 
43: XML         IDEA XML File -- Filing Summary                      XML     90K 
79: XML.R1      Document and Entity Information                      XML    121K 
33: XML.R2      Condensed Consolidated Balance Sheets                XML    279K 
54: XML.R3      Condensed Consolidated Balance Sheets                XML     89K 
                (Parenthetical)                                                  
42: XML.R4      Condensed Consolidated Statements of Operations      XML    294K 
                (Unaudited)                                                      
39: XML.R5      Condensed Consolidated Statements of Stockholders'   XML   1.71M 
                Equity (Deficit) (Unaudited)                                     
12: XML.R6      Condensed Consolidated Statements of Cash Flows      XML    504K 
                (Unaudited)                                                      
49: XML.R7      Condensed Consolidated Statements of Cash Flows      XML    142K 
                (Unaudited) (Parenthetical)                                      
11: XML.R8      Change in Fiscal Year End                            XML     40K 
25: XML.R9      Description of Business and Summary of Significant   XML    102K 
                Accounting Policies                                              
38: XML.R10     Derivative Liability                                 XML     58K 
30: XML.R11     Stockholders' Equity                                 XML    115K 
26: XML.R12     Commitments and Contingencies                        XML     54K 
66: XML.R13     Concentrations                                       XML     41K 
32: XML.R14     Subsequent Events                                    XML     44K 
75: XML.R15     Description of Business and Summary of Significant   XML    266K 
                Accounting Policies (Policies)                                   
51: XML.R16     Description of Business and Summary of Significant   XML     70K 
                Accounting Policies (Tables)                                     
50: XML.R17     Derivative Liability (Tables)                        XML     53K 
53: XML.R18     Stockholders' Equity (Tables)                        XML    127K 
23: XML.R19     Commitments and Contingencies (Tables)               XML     45K 
46: XML.R20     Description of Business and Summary of Significant   XML    304K 
                Accounting Policies (Details)                                    
60: XML.R21     Description of Business and Summary of Significant   XML    187K 
                Accounting Policies (Details 1)                                  
63: XML.R22     Description of Business and Summary of Significant   XML   4.68M 
                Accounting Policies (Details Textual)                            
67: XML.R23     Derivative Liability (Details)                       XML    155K 
37: XML.R24     Derivative Liability (Details Textual)               XML    258K 
20: XML.R25     Stockholders' Equity (Details)                       XML    101K 
69: XML.R26     Stockholders' Equity (Details 1)                     XML    221K 
52: XML.R27     Stockholders' Equity (Details 2)                     XML     90K 
70: XML.R28     Stockholders' Equity (Details 3)                     XML    297K 
17: XML.R29     Stockholders' Equity (Details 4)                     XML    124K 
58: XML.R30     Stockholders' Equity (Details Textual)               XML   6.50M 
57: XML.R31     Commitments and Contingencies (Details)              XML     73K 
19: XML.R32     Commitments and Contingencies (Details Textual)      XML     94K 
73: XML.R33     Subsequent Events (Details Textual)                  XML    658K 
40: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    716K 
 5: EX-101.INS  XBRL Instance -- onvo-20130630                       XML    957K 
 7: EX-101.CAL  XBRL Calculations -- onvo-20130630_cal               XML    139K 
 8: EX-101.DEF  XBRL Definitions -- onvo-20130630_def                XML    436K 
 9: EX-101.LAB  XBRL Labels -- onvo-20130630_lab                     XML    990K 
10: EX-101.PRE  XBRL Presentations -- onvo-20130630_pre              XML    714K 
 6: EX-101.SCH  XBRL Schema -- onvo-20130630                         XSD    147K 
41: ZIP         XBRL Zipped Folder -- 0001193125-13-329393-xbrl      Zip    118K

‘R5’   —   Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited)

This is an IDEA Financial Report.  [ Alternative Formats ]

 
v2.4.0.8
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) (USD $)
Total
Common Stock
Additional Paid-in Capital
Deficit Accumulated During the Development Stage
Beginning balance at Apr. 19, 2007            
Beginning balance, Shares at Apr. 19, 2007         
Issuance of Common stock         
Stock-based compensation expense            
Net Loss            
Ending balance at Dec. 31, 2007            
Ending balance, Shares at Dec. 31, 2007         
Issuance of Common stock to founders   2,000 (2,000)  
Issuance of Common stock to founders, Shares   1,730,000    
Issuance of restricted common stock   12,000 (12,000)  
Issuance of restricted common stock, Shares   12,628,000    
Stock-based compensation expense 2,000   2,000  
Net Loss (98,000)     (98,000)
Ending balance at Dec. 31, 2008 (96,000) 14,000 (12,000) (98,000)
Ending balance, Shares at Dec. 31, 2008   14,358,000    
Issuance of restricted common stock, Shares   130,000    
Stock-based compensation expense 2,000   2,000  
Net Loss (872,000)     (872,000)
Ending balance at Dec. 31, 2009 (966,000) 14,000 (10,000) (970,000)
Ending balance, Shares at Dec. 31, 2009   14,488,000    
Issuance of restricted common stock, Shares   219,000    
Stock-based compensation expense 4,000   4,000  
Net Loss (1,339,000)     (1,339,000)
Ending balance at Dec. 31, 2010 (2,301,000) 14,000 (6,000) (2,309,000)
Ending balance, Shares at Dec. 31, 2010   14,707,000    
Issuance of Common stock through conversion of notes payable 3,490,000 8,000 3,482,000  
Issuance of Common stock through conversion of notes payable, Shares   7,677,000    
Issuance of warrants to consultants/Warrants issued with convertible notes and conversion of notes 1,111,000   1,111,000  
Issuance of restricted common stock, Shares   61,000    
Beneficial conversion feature of convertible notes payable 239,000   239,000  
Stock-based compensation expense 9,000   9,000  
Net Loss (4,383,000)     (4,383,000)
Ending balance at Dec. 31, 2011 (1,835,000) 22,000 4,835,000 (6,692,000)
Ending balance, Shares at Dec. 31, 2011   22,445,000    
Issuance of Common stock in connection with the merger   6,000 (6,000)  
Issuance of Common stock in connection with the merger, Shares   6,000,000    
Issuance of Common stock through private placements in connection with merger 13,723,000 14,000 13,709,000  
Issuance of Common stock through private placements in connection with merger, Shares   13,723,000    
Costs associated with the merger (13,723,000)   (13,723,000)  
Issuance of Common stock through conversion of notes payable and accrued interest in connection with the merger 1,526,000 2,000 1,524,000  
Issuance of Common stock through conversion of notes payable and accrued interest in connection with the merger, Shares   1,525,000    
Issuance of warrants to consultants/Warrants issued with convertible notes and conversion of notes 890,000   890,000  
Issuance of Common stock from warrant exercises, net 10,991,000 14,000 10,977,000  
Issuance of Common stock from warrant exercises, net, Shares   13,424,000    
Issuance of restricted common stock   1,000 (1,000)  
Issuance of restricted common stock, Shares   1,380,000    
Restricted stock forfeitures and adjustments   (186,000)    
Warrant liability removed due to exercises of warrants 23,321,000   23,321,000  
Issuances of Common stock from stock option exercises 18,000   18,000  
Issuances of Common stock from stock option exercises, Shares 224,064 224,000    
Stock-based compensation expense 1,435,000   1,435,000  
Loss on inducement to exercise warrants 1,904,000   1,904,000  
Net Loss (43,553,000)     (43,553,000)
Ending balance at Dec. 31, 2012 (5,303,000) 59,000 44,883,000 (50,245,000)
Ending balance, Shares at Dec. 31, 2012   58,535,000    
Issuance of Common stock from warrant exercises, net 3,724,000 6,000 3,718,000  
Issuance of Common stock from warrant exercises, net, Shares   6,131,000    
Issuance of restricted common stock, Shares   55,000    
Restricted stock forfeitures and adjustments   (34,000)    
Warrant liability removed due to exercises of warrants 23,869,000   23,869,000  
Stock-based compensation expense 848,000   848,000  
Expense related to modification of warrants 65,000   65,000  
Warrant liability reclassified to equity 1,886,000   1,886,000  
Net Loss (16,120,000)     (16,120,000)
Ending balance at Mar. 31, 2013 8,969,000 65,000 75,269,000 (66,365,000)
Ending balance, Shares at Mar. 31, 2013   64,687,000    
Issuance of warrants to consultants/Warrants issued with convertible notes and conversion of notes 767,000      
Issuance of Common stock from warrant exercises, net            
Issuance of Common stock from warrant exercises, net, Shares   200,000    
Issuance of restricted common stock            
Issuance of restricted common stock, Shares   60,000    
Restricted stock forfeitures and adjustments   4,000    
Warrant liability removed due to exercises of warrants 129,000    129,000   
Issuances of Common stock from stock option exercises, Shares         
Stock-based compensation expense 802,000    802,000   
Expense related to modification of warrants 12,000    12,000   
Warrant liability reclassified to equity 767,000    767,000   
Net Loss (3,771,000)       (3,771,000)
Ending balance at Jun. 30, 2013 $ 6,908,000 $ 65,000 $ 76,979,000 $ (70,136,000)
Ending balance, Shares at Jun. 30, 2013   64,951,000    
↑Top
Filing Submission 0001193125-13-329393   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., Apr. 30, 5:12:25.1am ET